Dr. Gong on Adverse Events of TKI VEGF-Directed Therapy in RCC
Jun Gong, MD, fellow, City of Hope, discusses adverse events (AEs) associated with TKI/VEGF-directed therapy for patients with metastatic renal cell carcinoma (RCC).